Dimensional Fund Advisors’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.61M | Sell |
1,276,538
-26,683
| -2% | -$201K | ﹤0.01% | 2289 |
|
|
2025
Q1 | $9.87M | Sell |
1,303,221
-15,151
| -1% | -$115K | ﹤0.01% | 2256 |
|
|
2024
Q4 | $16.1M | Buy |
1,318,372
+295,467
| +29% | +$3.6M | ﹤0.01% | 2087 |
|
|
2024
Q3 | $17.1M | Buy |
1,022,905
+263,145
| +35% | +$4.41M | ﹤0.01% | 2073 |
|
|
2024
Q2 | $13.2M | Sell |
759,760
-233,617
| -24% | -$4.07M | ﹤0.01% | 2138 |
|
|
2024
Q1 | $16.9M | Buy |
993,377
+77,619
| +8% | +$1.32M | ﹤0.01% | 2071 |
|
|
2023
Q4 | $9.33M | Buy |
915,758
+117,042
| +15% | +$1.19M | ﹤0.01% | 2348 |
|
|
2023
Q3 | $7.23M | Buy |
798,716
+276,049
| +53% | +$2.5M | ﹤0.01% | 2400 |
|
|
2023
Q2 | $5.62M | Buy |
522,667
+176,448
| +51% | +$1.9M | ﹤0.01% | 2481 |
|
|
2023
Q1 | $3.54M | Buy |
346,219
+190,541
| +122% | +$1.95M | ﹤0.01% | 2590 |
|
|
2022
Q4 | $1.64K | Buy |
155,678
+144,394
| +1,280% | +$1.52K | ﹤0.01% | 2773 |
|
|
2022
Q3 | $145K | Buy |
+11,284
| New | +$145K | ﹤0.01% | 3288 |
|